Pharmaceutics
Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer.
Bartosz Dmuchowski, Witold Wit Hryniewicz, Igor Barczak, Kacper Fręśko, Zuzanna Szarzyńska, Hubert Węclewski, Jan Kazimierz Ślężak, Paula Dobosz, Hanna Gryczka
Published: 202510.3390/pharmaceutics18010034
Abstract
Breast cancer remains the most commonly diagnosed malignancy among women worldwide and continues to pose significant therapeutic challenges, particularly in advanced and refractory disease. Although traditionally considered less immunogenic compared…
Preview only. Read the full abstract at the source